Sophrosyne Technologies

Sophrosyne Technologies specializes in fabless semiconductor design, creating biosensing SoCs that monitor vital signs like ECG, PPG, respiration, and temperature with minimal energy use. These chips integrate analog signal acquisition, edge AI processing, and connectivity via Bluetooth and 5G for real-time data transmission to devices and cloud systems.

Core Products & Services

• Biosensing SoC Solutions – Ultra-low power, high-precision system-on-chip designs for monitoring vital signs including ECG, PPG, respiration, and temperature

• Wearable Health Devices – Continuous health tracking wearables with edge AI processing and Bluetooth/5G connectivity for real-time data transmission

• Remote Patient Monitoring Software – Cloud-based platform with AI-powered anomaly detection for in-hospital monitoring, long-term wearables, and clinical insights

• OEM Modules – Integrated hardware and firmware modules for original equipment manufacturers to embed into digital health devices

Business Model & Revenue Streams

• Fabless Semiconductor Model – Develops and licenses chip designs to manufacturers without owning fabrication facilities, reducing capital expenditure and enabling faster time-to-market

• B2B Healthcare Partnerships – Licenses biosensing SoCs and software platforms to healthcare providers, device manufacturers, and telehealth companies for integration into their ecosystems

• Wearable Device Sales – Direct revenue from branded wearable devices sold to consumers and enterprises for continuous health monitoring

• Licensing and IP Revenue – Monetizes through patent licensing, technology partnerships with OEMs, and government grants (secured $1.2M MeitY DLI grant for silicon development and scalable health monitoring solutions)